oritavancin
General
Pronunciation:
oh-rit-a-van-sin
To hear audio pronunciation of this topic, purchase a subscription or log in.Trade Name(s)
- Kimyrsa
- Orbactiv
Ther. Class.
anti-infectives
Pharm. Class.
lipoglycopeptides
There's more to see -- the rest of this topic is available only to subscribers.
Citation
Vallerand, April Hazard., and Cynthia A. Sanoski. "Oritavancin." Davis's Drug Guide, 20th ed., F.A. Davis Company, 2026. Pediatrics Central, peds.unboundmedicine.com/pedscentral/view/Davis-Drug-Guide/110180/11/oritavancin.
Vallerand AHA, Sanoski CAC. Oritavancin. Davis's Drug Guide. F.A. Davis Company; 2026. https://peds.unboundmedicine.com/pedscentral/view/Davis-Drug-Guide/110180/11/oritavancin. Accessed June 27, 2026.
Vallerand, A. H., & Sanoski, C. A. (2026). Oritavancin. In Davis's Drug Guide (20th ed.). F.A. Davis Company. https://peds.unboundmedicine.com/pedscentral/view/Davis-Drug-Guide/110180/11/oritavancin
Vallerand AHA, Sanoski CAC. Oritavancin [Internet]. In: Davis's Drug Guide. F.A. Davis Company; 2026. [cited 2026 June 27]. Available from: https://peds.unboundmedicine.com/pedscentral/view/Davis-Drug-Guide/110180/11/oritavancin.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - oritavancin
ID - 110180
A1 - Sanoski,Cynthia A,
AU - Vallerand,April Hazard,
BT - Davis's Drug Guide
UR - https://peds.unboundmedicine.com/pedscentral/view/Davis-Drug-Guide/110180/11/oritavancin
PB - F.A. Davis Company
ET - 20
DB - Pediatrics Central
DP - Unbound Medicine
ER -

Davis's Drug Guide

